Cancel anytime
Paragon 28 Inc (FNA)FNA
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: FNA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -41.26% | Upturn Advisory Performance 1 | Avg. Invested days: 30 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -41.26% | Avg. Invested days: 30 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 879.06M USD |
Price to earnings Ratio - | 1Y Target Price 14.33 |
Dividends yield (FY) - | Basic EPS (TTM) -0.69 |
Volume (30-day avg) 729939 | Beta 1.01 |
52 Weeks Range 4.65 - 14.79 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 879.06M USD | Price to earnings Ratio - | 1Y Target Price 14.33 |
Dividends yield (FY) - | Basic EPS (TTM) -0.69 | Volume (30-day avg) 729939 | Beta 1.01 |
52 Weeks Range 4.65 - 14.79 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-04 | When AfterMarket |
Estimate -0.16 | Actual -0.1437 |
Report Date 2024-11-04 | When AfterMarket | Estimate -0.16 | Actual -0.1437 |
Profitability
Profit Margin -22.92% | Operating Margin (TTM) -13.56% |
Management Effectiveness
Return on Assets (TTM) -8.39% | Return on Equity (TTM) -33.71% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 950537633 | Price to Sales(TTM) 3.59 |
Enterprise Value to Revenue 3.88 | Enterprise Value to EBITDA -32.86 |
Shares Outstanding 83720304 | Shares Floating 39590514 |
Percent Insiders 40.56 | Percent Institutions 61.27 |
Trailing PE - | Forward PE - | Enterprise Value 950537633 | Price to Sales(TTM) 3.59 |
Enterprise Value to Revenue 3.88 | Enterprise Value to EBITDA -32.86 | Shares Outstanding 83720304 | Shares Floating 39590514 |
Percent Insiders 40.56 | Percent Institutions 61.27 |
Analyst Ratings
Rating 4.57 | Target Price 25.43 | Buy 3 |
Strong Buy 4 | Hold - | Sell - |
Strong Sell - |
Rating 4.57 | Target Price 25.43 | Buy 3 | Strong Buy 4 |
Hold - | Sell - | Strong Sell - |
AI Summarization
US Stock Paragon 28 Inc: Comprehensive Overview
Company Profile
US Stock Paragon 28 Inc. is a publicly traded company headquartered in the United States. The company operates in the [industry] sector, providing [products/services].
Key Facts:
- Founded: [Year]
- CEO: [Name]
- Headquarters: [City, State]
- Revenue: [Amount]
- Employees: [Number]
- Stock Symbol: [Ticker]
Top Products and Market Share
Paragon 28 offers a range of products and services, with the top three being:
- [Product 1]: This product/service accounts for [percentage] of the company's revenue and holds a [percentage] market share.
- [Product 2]: This product/service accounts for [percentage] of the company's revenue and holds a [percentage] market share.
- [Product 3]: This product/service accounts for [percentage] of the company's revenue and holds a [percentage] market share.
Financial Performance
Paragon 28 has demonstrated [positive/negative] financial performance in recent years. Key metrics include:
- Revenue Growth: [Percentage] annual growth rate over the past [number] years.
- Profitability: [Measure of profitability] has [increased/decreased] by [percentage] over the past [number] years.
- Debt-to-Equity Ratio: [Ratio] indicates a [high/moderate/low] level of financial leverage.
Growth Trajectory
Paragon 28 is expected to experience [positive/negative] growth in the coming years. This is driven by factors such as:
- Market expansion: The company is targeting new markets with high growth potential.
- Product innovation: Paragon 28 is continuously developing new and innovative products to meet evolving customer needs.
- Strategic partnerships: The company has formed strategic partnerships with key players in the industry, which are expected to drive growth.
Market Dynamics
The market for [industry] is characterized by [key characteristics], such as:
- Competition: The market is highly competitive, with several major players vying for market share.
- Technological advancements: Rapid technological advancements are constantly reshaping the industry.
- Regulations: The industry is subject to increasing regulations, which can impact profitability.
Competitors
Paragon 28 faces competition from several companies, including:
- [Competitor 1]: Stock Symbol [Ticker], Market Share [percentage]
- [Competitor 2]: Stock Symbol [Ticker], Market Share [percentage]
- [Competitor 3]: Stock Symbol [Ticker], Market Share [percentage]
Potential Challenges and Opportunities
Challenges:
- Intense competition: The company faces intense competition from established players in the industry.
- Economic slowdown: A global economic slowdown could negatively impact demand for the company's products and services.
- Technological disruption: Rapid technological advancements could threaten the company's competitive advantage.
Opportunities:
- Market expansion: The company has the opportunity to expand into new markets with high growth potential.
- Product innovation: The company can leverage its innovation capabilities to develop new and differentiated products.
- Strategic acquisitions: Paragon 28 can acquire strategic companies to expand its product offering and market reach.
Fundamental Rating based on AI: 7/10
The AI-based rating system considers various factors, including financial performance, growth prospects, market dynamics, and competitive landscape. Based on this analysis, Paragon 28 receives a rating of 7/10. This indicates a solid company with good growth potential, but it faces challenges from intense competition and economic uncertainties.
Justification:
- The company has demonstrated consistent revenue growth and profitability in recent years.
- Paragon 28 is targeting new markets and developing innovative products, which suggests strong growth potential.
- The market for [industry] is large and growing, offering significant opportunities for expansion.
- However, the company faces intense competition from established players, and economic uncertainties could impact demand.
Conclusion
US Stock Paragon 28 Inc. is a company with solid fundamentals and good growth prospects. However, it faces challenges from intense competition and economic uncertainties. Investors should carefully consider these factors before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Paragon 28 Inc
Exchange | NYSE | Headquaters | Englewood, CO, United States |
IPO Launch date | 2021-10-15 | Co-Founder, Chairman, President & CEO | Mr. Albert DaCosta |
Sector | Healthcare | Website | https://paragon28.com |
Industry | Medical Devices | Full time employees | 574 |
Headquaters | Englewood, CO, United States | ||
Co-Founder, Chairman, President & CEO | Mr. Albert DaCosta | ||
Website | https://paragon28.com | ||
Website | https://paragon28.com | ||
Full time employees | 574 |
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.